| 000 | 01593 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513042510.0 | ||
| 264 | 0 | _c19950622 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0931-0509 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarenberg, J | |
| 245 | 0 | 0 |
_aMonitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay. _h[electronic resource] |
| 260 |
_bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _c1995 |
||
| 300 |
_a217-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Coagulation Tests _xmethods |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aFactor Xa _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xblood |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOligopeptides |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aHaaf, B | |
| 700 | 1 | _aDempfle, C E | |
| 700 | 1 | _aStehle, G | |
| 700 | 1 | _aHeene, D L | |
| 773 | 0 |
_tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _gvol. 10 _gno. 2 _gp. 217-22 |
|
| 999 |
_c7752825 _d7752825 |
||